Back to Search
Start Over
Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
- Source :
- Arthritis Research and Therapy, Arthritis Research and Therapy, BioMed Central, 2015, 17 (1), pp.71. ⟨10.1186/s13075-015-0572-y⟩, Arthritis Research and Therapy, 2015, 17 (1), pp.71. ⟨10.1186/s13075-015-0572-y⟩, Arthritis Research & Therapy, Arthritis Research and Therapy, BioMed Central, 2015, 17 (1), pp.71. 〈10.1186/s13075-015-0572-y〉
- Publication Year :
- 2015
- Publisher :
- HAL CCSD, 2015.
-
Abstract
- Introduction Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was undertaken to investigate whether single-nucleotide polymorphisms (SNPs) identified by a large genome-wide association study (GWAS) in PBC might contribute to SSc susceptibility. Methods Sixteen PBC susceptibility SNPs were genotyped in a total of 1,616 patients with SSc and 3,621 healthy controls from two European populations (France and Italy). Results We observed an association between PLCL2 rs1372072 (odds ratio (OR) = 1.22, 95% confidence interval (CI) 1.12 to 1.33, Padj = 7.22 × 10−5), nuclear factor-kappa-B (NF-κB) rs7665090 (OR = 1.15, 95% CI 1.06 to 1.25, Padj = 0.01), and IRF8 rs11117432 (OR = 0.75, 95% CI 0.67 to 0.86, Padj = 2.49 × 10−4) with SSc susceptibility. Furthermore, phenotype stratification showed an association between rs1372072 and rs11117432 with the limited cutaneous subgroup (lcSSc) (Padj = 4.45 × 10−4 and Padj = 0.001), whereas rs7665090 was associated with the diffuse cutaneous subtype (dcSSc) (Padj = 0.003). Genotype-mRNA expression correlation analysis revealed that the IRF8 protective allele was associated with increased interferon-gamma (IFN-γ) expression (P = 0.03) in patients with SSc but decreased type I IFN (IFIT1) expression in patients and controls (P = 0.02). In addition, we found an epistatic interaction between NF-κB and IRF8 (OR = 0.56, 95% CI 0.00 to 0.74, P = 4 × 10−4) which in turn revealed that the IRF8 protective effect is dependent on the presence of the NF-κB susceptibility allele. Conclusions An analysis of pleiotropic genes identified two new susceptibility genes for SSc (NF-κB and PLCL2) and confirmed the IRF8 locus. Furthermore, the IRF8 variant influenced the IFN signature, and we found an interaction between IRF8 and NF-κB gene variants that might play a role in SSc susceptibility. Electronic supplementary material The online version of this article (doi:10.1186/s13075-015-0572-y) contains supplementary material, which is available to authorized users.
- Subjects :
- Adult
Male
Immunology
Locus (genetics)
Genome-wide association study
Single-nucleotide polymorphism
Polymorphism, Single Nucleotide
Follow-Up Studie
03 medical and health sciences
Interferon-gamma
0302 clinical medicine
Primary biliary cirrhosis
Rheumatology
Pleiotropism
medicine
[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology
Humans
Immunology and Allergy
Genetic Predisposition to Disease
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Allele
skin and connective tissue diseases
Interferon Regulatory Factor
030304 developmental biology
Aged
030203 arthritis & rheumatology
0303 health sciences
Scleroderma, Systemic
business.industry
Intracellular Signaling Peptides and Proteins
Case-control study
NF-kappa B
Odds ratio
Middle Aged
medicine.disease
3. Good health
Intracellular Signaling Peptides and Protein
Case-Control Studies
Interferon Regulatory Factors
Female
business
Case-Control Studie
Research Article
Follow-Up Studies
Human
Subjects
Details
- Language :
- English
- ISSN :
- 14786354
- Database :
- OpenAIRE
- Journal :
- Arthritis Research and Therapy, Arthritis Research and Therapy, BioMed Central, 2015, 17 (1), pp.71. ⟨10.1186/s13075-015-0572-y⟩, Arthritis Research and Therapy, 2015, 17 (1), pp.71. ⟨10.1186/s13075-015-0572-y⟩, Arthritis Research & Therapy, Arthritis Research and Therapy, BioMed Central, 2015, 17 (1), pp.71. 〈10.1186/s13075-015-0572-y〉
- Accession number :
- edsair.doi.dedup.....a9a3df5e3a9993337e71c5bd2f2c2b7a
- Full Text :
- https://doi.org/10.1186/s13075-015-0572-y⟩